Exercise training initiated after the onset of diabetes preserves myocardial function: Effects on expression of β-adrenoceptors

Journal of Applied Physiology

Volumn 105, Issue 3, 2008, Pages 907-914

  Bidasee, Keshore R ^a   Zheng, Hong ^a   Shao, Chun Hong ^a   Parbhu, Sheeva K ^a   Rozanski, George J ^a   Patel, Kaushik P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Contractility; Heart; Isoproterenol; Rats; Streptozotocin

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; STREPTOZOCIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIHYDROALPRENOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; EXERCISE; HEART EJECTION FRACTION; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART RATE; INSULIN DEPENDENT DIABETES MELLITUS; M MODE ECHOCARDIOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SITTING; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; ECHOCARDIOGRAPHY; EXPERIMENTAL DIABETES MELLITUS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEMODYNAMICS; KINESIOTHERAPY; METABOLISM; PATHOPHYSIOLOGY; PROTEIN BINDING; TIME;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIHYDROALPRENOLOL; ECHOCARDIOGRAPHY; EXERCISE THERAPY; HEART RATE; HEMODYNAMICS; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 53049096984     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00103.2008     Document Type: Article

References (52)

1. Ades PA, Green NM, Coello CE. Effects of exercise and cardiac rehabilitation on cardiovascular outcomes. Cardiol Clin 21: 435-448, 2003.
2. Altan VM, Arioglu E, Guner S, Ozcelikay AT. The influence of diabetes on cardiac beta-adrenoceptor subtypes. Heart Fail Rev 12: 58-65, 2007.
3. American Diabetes Association. Complications of Diabetes in the United States.(http://www.diabetes.org/diabetes-statistics/complications. jsp).
4. 3-Adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 440: 99-107, 2002.
5. Baldwin KM. Effects of chronic exercise on biochemical and functional properties of the heart. Med Sci Sports Exerc 17: 522-528, 1985.
6. 3-adrenergic and M2 muscarinic receptors in rat heart. Med Sci Sports Exerc 36: 949-954, 2004.
7. Berchtold P, Berger M, Cuppers HJ, Herrmann J, Nieschlag E, Rudorff K, Zimmermann H, Kruskemper HL. Non-glucoregulatory hormones (T4, T3, rT3, TSH, testosterone) during physical exercise in juvenile type diabetics. Horm Metab Res 10: 269-273, 1978.
8. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
9. 2+-ATPase. Diabetes 53: 463-473, 2004.
10. Bryan LJ, Cole JJ, O'Donnell SR, Wanstall JC. A study designed to explore the hypothesis that beta-1 adrenoceptors are "innervated" receptors and beta-2 adrenoceptors are "hormonal" receptors. J Pharmacol Exp Ther 216: 395-400, 1981.
11. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2007 (http: //www.diabetes.org/diabetes-statistics.jsp).
12. Charlton GA, Crawford MH. Physiologic consequences of training. Cardiol Clin 15: 345-354, 1997.
13. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91, 1997.
14. DeBlieux PM, Barbee RW, McDonough KH, Shepherd RE. Exercise training improves cardiac performance in diabetic rats. Proc Soc Exp Biol Med 203: 209-213, 1993.
15. 3-adrenoreceptors in rat hearts. Diabetes 50: 455-461, 2001.
16. 2- adrenoreceptors in human diabetic atrial appendage. Cardiovasc Diabetol 2: 6-14, 2003.
17. Dubach P, Sixt S, Myers J. Exercise training in chronic heart failure: why, when and how. Swiss Med Wkly 131: 510-514, 2001.
18. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25: 543-567, 2004.
19. Fein FS. Diabetic cardiomyopathy. Diabetes Care 13, Suppl 4: 1169-1179, 1990.
20. Fève B, Elhadri K, Quignard-Boulange A, Pairault J. Transcriptional down-regulation by insulin of the beta 3-adrenergic receptor expression in 3T3-F442A adipocytes: a mechanism for repressing the cAMP signaling pathway. Proc Natl Acad Sci USA 91: 5677-5681, 1994.
21. Foy JM, Lucas PD. Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to autonomic agents. Br J Pharmacol 57: 229-234, 1976.
22. Gando S, Hattori Y, Akaishi Y, Nishihira J, Kanno M. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther 282: 475-484, 1997.
23. Heller BA, Paulson DJ, Kopp SJ, Peace DG, Tow JP. Depressed in vivo myocardial reactivity to dobutamine in streptozotocin diabetic rats: influence of exercise training. Cardiovasc Res 22: 417-424, 1988.
24. Heyliger CE, Pierce GN, Singal PK, Beamish RE, Dhalla NS. Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol 77: 610-618, 1982.
25. Howarth FC, Jacobson M, Naseer O, Adeghate E. Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90: 237-245, 2005.
26. Kashiwagi A, Nishio Y, Saeki Y, Kida Y, Kodama M, Shigeta Y. Plasma membrane-specific deficiency in cardiac beta-adrenergic receptor in streptozocin-diabetic rats. Am J Physiol Endocrinol Metab 257: E127-E132, 1989.
27. Loganathan R, Bilgen M, Al-Hafez B, Zhero SV, Alenezy MD, Smirnova IV. Exercise training improves cardiac performance in diabetes: in vivo demonstration with quantitative cine-MRI analyses. J Appl Physiol 102: 665-672, 2007.
28. Machackova J, Barta J, Dhalla NS. Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies. Can J Cardiol 22: 953-968, 2006.
29. 1-AR mRNA expression in rat heart. Biochem Pharmacol 58: 881-885, 1999.
30. Mayhan WG, Sun H, Mayhan JF, Patel KP. Influence of exercise on dilatation of the basilar artery during diabetes mellitus. J Appl Physiol 96: 1730-1737, 2004.
31. Molenaar P, Parsonage WA. Fundamental considerations of beta-adrenoceptor subtypes in human heart failure. Trends Pharmacol Sci 26: 368-375, 2005.
32. Musch TI, Terrell JA. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise. Am J Physiol Heart Circ Physiol 262: H411-H419, 1992.
33. Plourde G, Martin M, Rousseau-Migneron S, Nadeau A. Effect of physical training on ventricular beta-adrenergic receptor adenylate cyclase system of diabetic rats. Metabolism 40: 362-367, 1991.
34. Powers SK, Lennon SL, Quindry J, Mehta JL. Exercise and cardioprotection. Curr Opin Cardiol 17: 495-502, 2002.
35. Ramanadham S, McNeill JH, Tenner TE Jr. Experimentally induced effects of diabetes on the rat myocardial beta-adrenoceptor system. Proc West Pharmacol Soc 29: 23-25, 1986.
36. Riddell MC, Iscoe KE. Physical activity, sport, and pediatric diabetes. Pediatr Diabetes 7: 60-70, 2006.
37. Saito K, Kuroda A, Tanaka H. Characterisation of beta 1 and beta 2 adrenoceptor subtypes in the atrioventricular node of diabetic rat hearts by quantitative autoradiography. Cardiovasc Res 25: 950-954, 1991.
38. Savarese JJ, Berkowitz BA. Beta-adrenergic receptor decrease in diabetic rat hearts. Life Sci 25: 2075-2078, 1979.
39. 2+ release in myocytes from streptozotocin-induced diabetic rats. J Mol Cell Cardiol 42: 234-246, 2007.
40. Smith ML, Hudson DL, Graitzer HM, Raven PB. Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc 21: 40-44, 1989.
41. Smrcka AV, Oestreich EA, Blaxall BC, Dirksen RT. EPAC regulation of cardiac EC coupling. J Physiol 584: 1029-1031, 2007.
42. Srere PA. Citrate synthase. Methods Enzymol 13: 3-5, 1969.
43. Stein R, Goldberg N, Kalman F, Chesler R. Exercise and the patient with Type I diabetes mellitus. Pediatr Clin North Am 31: 665-667, 1984.
44. Sundaresan PR, Sharma VK, Gingold SI, Banerjee SP. Decreased beta-adrenergic receptors in rat heart in streptozotocin-induced diabetes: role of thyroid hormones. Endocrinology 114: 1358-1363, 1984.
45. Tibbits GF, Hamman BN. Regulation of myocardial contractility. Med Sci Sports Exerc 23: 1140-1144, 1991.
46. Tong H, Bernstein D, Murphy E, Steenbergen C. The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 19: 983-985, 2005.
47. Vrydag W, Michel MC. Tools to study β3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 374: 385-398, 2007.
48. Woodiwiss AJ, Kalk WJ, Norton GR. Habitual exercise attenuates myocardial stiffness in diabetes mellitus in rats. Am J Physiol Heart Circ Physiol 271: H2126-H2133, 1996.
49. 3-Adrenoceptor antagonism improves clinical outcomes of chronic heart failure. Med Hypotheses 69: 1114-1116, 2007.
50. 2+ homeostasis in rat heart. Diabetes 54: 3082-3088, 2005.
51. Zimmet P, Alberti KG, Shaw J. Global and societal implications of diabetes epidemic. Nature 414: 782-782, 2001.
52. Zucker IH, Patel KP, Schultz HD, Li YF, Wang W, Pliquett RU. Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev 32: 107-111, 2004.